TickerFacts.

Korsana Biosciences, Inc. (KRSA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$12.95M
Year ended 2023-12-31
2018-12-31: -$113.72M2019-12-31: -$122.34M2020-12-31: -$78.97M2021-12-31: -$54.72M2022-12-31: -$18.48M2023-12-31: -$12.95M-$12.95M
2018-12-31 EBITDA (USD) 2023-12-31
Period endedEBITDAChange YoYSource filing
2023-12-31-$12.95Mn/m2025-11-12, From 2023-01-01
2022-12-31-$18.48Mn/m2024-03-05, From 2022-01-01
2021-12-31-$54.72Mn/m2023-03-22, From 2021-01-01
2020-12-31-$78.97Mn/m2022-02-24, From 2020-01-01
2019-12-31-$122.34Mn/m2021-02-25, From 2019-01-01
2018-12-31-$113.72Mn/a2020-03-12, From 2018-01-01